Pyxis Oncology, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.09 | -100% | -2.3 | -100% |
| P/S |
|
0 | 33.5 | -100% |
|
|
| P/BV |
|
0.5524 | 4.61 | -88.03% |
|
|
| P/FCF |
|
-1.11 | 39.66 | -102.79% |
|
|
| Ev/Ebitda |
|
-0.9929 | -19.46 | -94.9% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-1.03 | 45.47 | -102.26% |
|
|
| E/P |
|
-0.86 | 0.0172 | -5086.27% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -14.42 | -100% | 0 | 0% |
| ROE |
|
-58.7 | 9.01 | -751.49% |
|
|
| ROA |
|
-42.47 | 0.0151 | -280560.02% |
|
|
| ROIC |
|
-30.22 | 7.63 | -495.84% |
|
|
| ROS |
|
0 | -26.5 | -100% |
|
|
| ROCE |
|
-65.39 | 13.75 | -575.46% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.266 | -3.73 | -92.87% | -0.1921 | +38.47% |
| Nеt Debt/Ebitda |
|
-0.1271 | -3.19 | -96.02% |
|
|
| Debt/Ratio |
|
0.1228 | 0.1777 | -30.91% |
|
|
| Debt/Equity |
|
1.9 | 1.57 | 21.19% |
|
|
| Debt/Net Income |
|
-0.2891 | 0.8429 | -134.29% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 73.67 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
2626.4 | 15.28 | 17088.48% | ||
| Growth impulse Net Income in 5 years |
|
2359.67 | -33.08 | -7233.22% | ||
| Growth impulse FCF in 5 years |
|
3771.75 | -6.99 | -54059.23% | ||
| Growth impulse EPS in 5 years |
|
1322.43 | -59.11 | -2337.24% |
IP Score
4.23/10
